Eli Lilly Company

Date	Subject
06/23/97
	Active Treatment Of Diabetes Can Reduce Complications
05/23/97
	ILEX And PRN To Develop Anti-Cancer Agents For Lilly
05/21/97
	Prozac May Be First Effective Drug Treatment for Anorexia Nervosa -- Study
	Study Compares Two Main Schizophrenia Drugs
04/23/97
	Study Shows New Schizophrenia Drug is Safer, More Effective
01/16/97
	Gemzar Findings From Phase II Lung Cancer Study Are Reported
12/11/96
	Humatrope Recommended by FDA for Turner Syndrome
12/05/96
	Agreement To Develop Compounds for Gastrointestinal Market Expanded
12/04/96
	Genetics-Based Atherosclerosis Target Ready for Drug Candidate Screening
11/25/96
	Prozac Cleared by FDA for Treatment of Bulimia
11/07/96
	Research Agreement Signed to Develop Antifungal Drugs
11/01/96
	Zyprexa Schizophrenia Drug Approved in Canada
10/21/96
	Research and Development Targeting Obesity and Alzheimer's Disease
10/02/96
	Medical Experts Dispute Findings in NEJM Study
10/01/96
	Zyprexa Cleared by the FDA for Treatment of Psychotic Disorders
09/27/96
	Zyprexa Cleared for Marketing in European Union for Schizophrenia
08/26/96
	ReoPro Prevents Angioplasty Complications Years After Single Treatment
08/12/96
	Humalog Now Available for Diabetes
	Survey Finds Exercise, Diet Are Greatest Challenges in Diabetes Regimen
08/08/96
	Humatrope Approved for Somatropin Deficiency Syndrome in Adults
06/25/96
	Prozac Shown to be Cost Efficient, While Producing Fewer Side Effects
06/17/96
	Humalog Approved by the FDA as First New Insulin in 14 Years
05/16/96
	Gemzar Cleared by FDA for Pancreatic Cancer
05/02/96
	Humalog Approved by the European Medicine Evaluation Agency
04/30/96
	Ethyol Approved for Marketing in Canada
02/21/96
	Prozac Added to Medi-Cal Formulary, California's Medicaid Program
12/15/95
	Clinical Trials Suggest Olanzapine May Treat Symptoms of Schizophrenia

More "Top of the News" stories